Pulmonary artery banding in infants and young children with end-stage left ventricular dilated cardiomyopathy-Cohort Study.
Min ZengFan YangChao YueWei WeiKai MaZheng DouQuanlin LiXu WangShoujun LiPublished in: International journal of surgery (London, England) (2024)
Pulmonary artery banding is safe and effective in infants and young children with end-stage DCM with preserved right ventricular function. Combined with conventional heart failure medication therapy, it may provide short-term benefits post-operatively, decrease the cardiogenic shock, and act as a bridge to recovery and potentially reduce the need for heart transplantation. Long-term effects remain further observation, and larger randomized controlled trials would be more persuasive in validating its efficacy.
Keyphrases
- pulmonary artery
- heart failure
- left ventricular
- coronary artery
- pulmonary hypertension
- pulmonary arterial hypertension
- randomized controlled trial
- cardiac resynchronization therapy
- hypertrophic cardiomyopathy
- acute myocardial infarction
- healthcare
- aortic stenosis
- mitral valve
- adverse drug
- stem cells
- systematic review
- acute heart failure
- clinical trial
- coronary artery disease
- study protocol
- aortic valve
- transcatheter aortic valve replacement